Inhibition of human immunodeficiency virus type 1 long terminal repeat-driven transcription by an in vivo metabolite of oltipraz: Implications for antiretroviral therapy

Biochemical and Biophysical Research Communications

Volumn 221, Issue 3, 1996, Pages 548-553

  Prochaska, Hans J ^a   Fernandes, Christabel L ^a   Pantoja, Rosa M ^a   Chavan, Surendra J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 METHYL 6,8 BIS(METHYLTHIO)PYRROLO[1,2 ALPHA]PYRAZINE; ANTIVIRUS AGENT; BETA GALACTOSIDASE; DNA; DRUG METABOLITE; OLTIPRAZ; PHORBOL 13 ACETATE 12 MYRISTATE; PYRAZINE DERIVATIVE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ELECTROPHORETIC MOBILITY; GENE REPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION; VIRUS GENE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030001461     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1996.0633     Document Type: Article

References (20)

1. Benson, A. B., III (1993) J. Cell. Biochem. Supplement 17F, 278-291.
2. Kensler, T. W., and Helzlsouer, K. J. (1995) J. Cell. Biochem. Supplement 22, 101-107.
3. Prochaska, H. J., Yeh, Y., Baron, P., and Polsky, B. (1993) Proc. Natl. Acad. Sci. 90, 3953-3957.
4. Prochaska, H. J., Rubinson, L., Yeh, Y., Baron, P., and Polsky, B. (1994) Mol. Pharmacol. 45, 916-921.
5. Prochaska, H. J., Chavan, S. J., Baron, P., and Polsky, B. (1995) J. Cell. Biochem. Supplement 22, 117-125.
6. Chavan, S. J., Bornmann, W. G., Flexner, C., and Prochaska, H. J. (1995) Arch. Biochem. Biophys. 324, 143-152.
7. Prochaska, H. J., Bornmann, W. G., Baron, P., and Polsky, B. (1995) Mol. Pharmacol. 48, 15-20.
8. Roederer, M., Staal, F. J. T., Raju, P. A., Ela, S. W., Herzenberg, L. A., and Herzenberg, L. A. (1990) Proc. Natl. Acad. Sci. 87, 4884-4888.
9. Prochaska, H. J. (1994) J. Nutr. Biochem. 5, 360-368.
10. Alley, M. C., Scudiero, D. A., Monks, A., Hursey, M. L., Czerwinski, M. J., Fine, D. L., Abbott, B. J., Mayo, J. G., Shoemaker, R. H., and Boyd, M. R. (1988) Cancer Res. 48, 589-601.
11. Chou, T. C., and Talalay, P. (1984) Adv. Enz. Regul. 22, 27-55.
12. Staal, F. J., Roederer, M., Herzenberg, L. A., and Herzenberg, L. A. (1990) Proc. Natl. Acad. Sci. 87, 9943-9947.
13. Staal, F. J. T., Roederer, M., Raju, P. A., Anderson, M. T., Ela, S. W., Herzenberg, L. A., and Herzenberg, L. A. (1993) AIDS Res. Hum. Retroviruses 9, 299-306.
14. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254.
15. Li, Y., Mak, G., and Franza, B. R., Jr. (1994) J. Biol. Chem. 269, 30616-30619.
16. Nare, B., Smith, J. M., and Prichard, R. K. (1992) Biochem. Pharmacol. 43, 1345-1351.
17. Egner, P. A., Kensler, T. W., Prestera, T., Talalay, P., Libby, A. H., Joyner, H. H., and Curphey, T. J. (1994) Carcinogenesis 15, 177-181.
18. Heusse, D., Marlard, M., Bredenbac, J., Decouvelaere, B., Leroy, J. P., Bieder, A., and Jumeau, H. (1985) ArzneimittelForschung. 35, 1431-1436.
19. Rao, C. V., Rivenson, A., Katiwalla, M., Kelloff, G. J., and Reddy, B. S. (1993) Cancer Res. 53, 2502-2506.
20. Roebuck, B. D., Liu, Y. L., Rogers, A. E., Groopman, J. D., and Kensler, T. W. (1991) Cancer Res. 51, 5501-5506.